awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38515085-242D7CD8-CA15-4150-875B-2E76CCF93890
Q38515085-242D7CD8-CA15-4150-875B-2E76CCF93890
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38515085-242D7CD8-CA15-4150-875B-2E76CCF93890
Clinical Pharmacokinetic, Pharmacodynamic, and Drug-Drug Interaction Profile of Canagliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor.
P2860
Q38515085-242D7CD8-CA15-4150-875B-2E76CCF93890
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38515085-242D7CD8-CA15-4150-875B-2E76CCF93890
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ba13944d831094b9faa13a9a42ad8fc1c3d4e8c5
P2860
Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial